Bharat Biotech on thursday, 20th May has said that they have ramped up the production of Covaxin. Chiron Behring, a subsidy of Bharat Biotech in Ankleshwar, Gujrat to produce 200 million doses of Covaxin per annum. This will take the Covaxin doses up to 1 billion per annum, according to the company.
Earlier, Bharat Biotech had deployed multiple production lines at its Hyderabad and Bengaluru campuses to meet the country’s growing need of vaccine. There was a drastic drop in the speed of the national vaccine drive due to depleted stocks of vaccine.
The company ramped up capacities at its own established campuses that are specialized in manufacturing inactivated viral vaccines under the highest levels of biosafety.
Discussion about this post